Ikarian Capital, LLC: 13F holdings
CIK 17782532026Q2
| Positions | 137 |
|---|---|
| Reported value | $928.2m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| ABIVAX SA | 328,635 | $43.4m | 4.7% |
| KOD KODIAK SCIENCES INC | 1,059,730 | $41.3m | 4.4% |
| ALUMIS INC | 870,548 | $24.5m | 2.6% |
| PRAX PRAXIS PRECISION MEDICINES I | 72,842 | $24.4m | 2.6% |
| PCVX VAXCYTE INC | 388,682 | $22.6m | 2.4% |
| ANIP ANI PHARMACEUTICALS INC | 272,085 | $22.5m | 2.4% |
| CLDX CELLDEX THERAPEUTICS INC NEW | 478,500 | $17.8m | 1.9% |
| RCUS ARCUS BIOSCIENCES INC | 504,559 | $15.6m | 1.7% |
| RELMADA THERAPEUTICS INC | 2,148,359 | $14.9m | 1.6% |
| CAPRICOR THERAPEUTICS INC | 604,215 | $14.5m | 1.6% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1778253")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.